Kolumne, ORE

Original-Research: THE NAGA GROUP AG - from NuWays AG 11.06.2025 / 09:00 CET / CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group.

11.06.2025 - 09:00:26

Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY

Original-Research: THE NAGA GROUP AG - from NuWays AG

11.06.2025 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS
Group.
The issuer is solely responsible for the content of this research. The
result of this research does not constitute investment advice or an
invitation to conclude certain stock exchange transactions.

---------------------------------------------------------------------------

Classification of NuWays AG to THE NAGA GROUP AG

     Company Name:                THE NAGA GROUP AG
     ISIN:                        DE000A161NR7

     Reason for the research:     Update
     Recommendation:              BUY
     from:                        11.06.2025
     Target price:                EUR 1.20
     Target price on sight of:    12 months
     Last rating change:
     Analyst:                     Frederik Jarchow

Final FY24 above prelims // Solid Q1 figures; chg

Last week, NAGA reported final FY24 figures that came in slightly above
prelims on top and bottom line.Further, the company reported preliminary Q1
figures.

  * FY24 Sales came in at EUR 63.2m (-18% yoy), above preliminary sales of EUR
    62.3m. The decline compared to the previous year is mainly coming from
    the closure of loss-making non-core subsegments. FY24 EBITDA stood at EUR
    9.0m (6% yoy vs EUR 8.5m preliminary EBITDA) resulting in an EBITDA-margin
    of 14.3% (vs 11.5% in FY23), thanks to higher synergy effects from the
    merger and increasing operational and marketing efficiency.


After the transition year 2024 that was mainly characterized by integration,
automation and efficiency processes, NAGA restarted its growth engine in
2025. First measures such as the cooperation with BVB and Mike Tyson were
already taken in Q4Ž24 and Q1Ž25. First effects on the topline were already
visible in Q1 figures:

  * Q1Ž25 sales of EUR 16.4m (7% yoy) carried by increased avg daily trades
    per customer of 2.31 (vs 2.09 in Q1Ž24) and an increased CLV of EUR 3,290
    (vs EUR 2,880 in Q1Ž24). EBITDA came in at EUR 1.0m, burdened by increased
    marketing spending that should start to materialize within the next
    quarters, visible in growing topline and scale effects.


In order to fuel topline growth, NAGA is expected to further ramp-up
marketing expenses (according to the guidance by >50% yoy in FY25e and
another 18% yoy to EUR 39m in FY26e). As a result, management is expecting
topline growth of 19% to EUR 74m in FY25 (eNuW: EUR 77.3m) and another 32% to EUR
97.8m in FY26 (vs eNuW: EUR 92.7m). Thanks to expected further synergies,
efficiency and scale effects, EBITDA should increase to EUR 12.5m in FY25 (vs
eNuW: EUR 12.4m) and EUR 27.6m in FY26 (vs eNuW: EUR 19.1m) implying margins of
17% and 28%.

With Q1 figures the company delivered a solid start into the year.
Nevertheless, it needs further sequential improvement to achieve the
guidance. We are convinced that the management took the right measures and
see the company on track to deliver.

BUY with an unchanged PT of EUR 1.20 based on DCF.

You can download the research here: http://www.more-ir.de/d/32830.pdf
For additional information visit our website:
https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss
bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben
analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

---------------------------------------------------------------------------

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

2153434 11.06.2025 CET/CEST

@ dpa.de

Weitere Meldungen

Original-Research: Marinomed Biotech AG (von GBC AG): Kaufen Original-Research: Marinomed Biotech AG - von GBC AG 12.06.2025 / 14:00 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. (Boerse, 12.06.2025 - 14:00) weiterlesen...

Original-Research: Almonty Industries Inc. (von Sphene Capital GmbH): Buy. - from Sphene Capital GmbH 12.06.2025 / 12:39 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group. Original-Research: Almonty Industries Inc. (Boerse, 12.06.2025 - 12:39) weiterlesen...

Original-Research: PORR AG (von Montega AG): Kaufen Original-Research: PORR AG - von Montega AG 11.06.2025 / 16:47 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. (Boerse, 11.06.2025 - 16:47) weiterlesen...

Original-Research: ÖKOWORLD AG (von BankM AG): Kaufen Original-Research: ÖKOWORLD AG - von BankM AG 11.06.2025 / 16:19 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. (Boerse, 11.06.2025 - 16:19) weiterlesen...

Original-Research: Swissnet AG (formerly Beaconsmind AG) (von First Berlin Eq... Original-Research: Swissnet AG (formerly Beaconsmind AG) - from First Berlin Equity Research GmbH 11.06.2025 / 14:41 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group. (Boerse, 11.06.2025 - 14:41) weiterlesen...

Original-Research: Ernst Russ AG (von Montega AG): Kaufen Original-Research: Ernst Russ AG - von Montega AG 11.06.2025 / 13:00 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. (Boerse, 11.06.2025 - 13:00) weiterlesen...